The pregnant women living with hiv antiretroviral therapy coverage for pmtct in Liberia has dropped to 86%, which is a decrease of 10% (-10.4%) since 2021.
Pregnant women living with HIV antiretroviral therapy coverage for PMTCT in Liberia
No matching regions
Source:
Data availability:
Regions:
215
Date range: 2000 to 2022
Points:
13,975
Measure:
%
More indicators for Liberia
Male unintentional poisoning
1.1
-0.1
(2021)
Female wasting in children
3.2%
0%
(2019)
Female prevalence of HIV
0.6%
0%
(2022)
Out-of-pocket expenditure PPP per capita
intl dollar140
+intl dollar8
(2022)
Birth registration
66.3%
+41.7%
(2020)
Contraceptive modern method prevalence
23.9%
+4.8%
(2020)
Liberia PMTCT antiretroviral therapy coverage between 2000 and 2022
| Period | Value | Change |
|---|---|---|
| 2022 | 86% | -10% |
| 2021 | 96% | +26% |
| 2020 | 70% | -24% |
| 2019 | 94% | +3% |
| 2018 | 91% | +14% |
| 2017 | 77% | +10% |
| 2016 | 67% | +13% |
| 2015 | 54% | +26% |
| 2014 | 28% | +2% |
| 2013 | 26% | -7% |
| 2012 | 33% | +1% |
| 2011 | 32% | +11% |
| 2010 | 21% | +7% |
| 2009 | 14% | +1% |
| 2008 | 13% | +11% |
| 2007 | 2% | +2% |
| 2006 | 0% | 0% |
| 2005 | 0% | 0% |
| 2004 | 0% | 0% |
| 2003 | 0% | 0% |
| 2002 | 0% | 0% |
| 2001 | 0% | 0% |
| 2000 | 0% |